BlackRock’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,305,512
| Closed | -$22.6M | – | 6004 |
|
|
2021
Q4 | $22.6M | Sell |
7,305,512
-282,970
| -4% | -$952K | ﹤0.01% | 3196 |
|
|
2021
Q3 | $27.4M | Buy |
7,588,482
+144,240
| +2% | +$544K | ﹤0.01% | 3074 |
|
|
2021
Q2 | $26.7M | Sell |
7,444,242
-1,144,355
| -13% | -$4.04M | ﹤0.01% | 3124 |
|
|
2021
Q1 | $33.6M | Buy |
8,588,597
+373,956
| +5% | +$1.54M | ﹤0.01% | 2879 |
|
|
2020
Q4 | $34.5M | Buy |
8,214,641
+696,022
| +9% | +$2.68M | ﹤0.01% | 2703 |
|
|
2020
Q3 | $28M | Sell |
7,518,619
-330,400
| -4% | -$1.41M | ﹤0.01% | 2670 |
|
|
2020
Q2 | $34.2M | Buy |
7,849,019
+685,680
| +10% | +$3.08M | ﹤0.01% | 2481 |
|
|
2020
Q1 | $27.1M | Sell |
7,163,339
-141,003
| -2% | -$693K | ﹤0.01% | 2439 |
|
|
2019
Q4 | $46.2M | Buy |
7,304,342
+1,716,174
| +31% | +$10.1M | ﹤0.01% | 2414 |
|
|
2019
Q3 | $23.5M | Buy |
5,588,168
+89,711
| +2% | +$383K | ﹤0.01% | 2724 |
|
|
2019
Q2 | $25.6M | Buy |
5,498,457
+4,040,621
| +277% | +$18.8M | ﹤0.01% | 2706 |
|
|
2019
Q1 | $7.73M | Buy |
1,457,836
+69,539
| +5% | +$318K | ﹤0.01% | 3236 |
|
|
2018
Q4 | $5.14M | Buy |
1,388,297
+189,508
| +16% | +$666K | ﹤0.01% | 3383 |
|
|
2018
Q3 | $3.36M | Buy |
1,198,789
+8,503
| +0.7% | +$23.9K | ﹤0.01% | 3617 |
|
|
2018
Q2 | $3.51M | Buy |
1,190,286
+30,991
| +3% | +$73.5K | ﹤0.01% | 3578 |
|
|
2018
Q1 | $2.61M | Sell |
1,159,295
-5,164
| -0.4% | -$12.1K | ﹤0.01% | 3609 |
|
|
2017
Q4 | $3.44M | Buy |
1,164,459
+8,204
| +0.7% | +$22.7K | ﹤0.01% | 3546 |
|
|
2017
Q3 | $3.41M | Sell |
1,156,255
-2,675
| -0.2% | -$8.15K | ﹤0.01% | 3579 |
|
|
2017
Q2 | $3.24M | Sell |
1,158,930
-59,909
| -5% | -$126K | ﹤0.01% | 3577 |
|
|
2017
Q1 | $2.31M | Buy |
+1,218,839
| New | +$2.35M | ﹤0.01% | 3618 |
|
|
2016
Q2 | – | Sell |
-2,912
| Closed | -$9K | – | 3948 |
|
|
2016
Q1 | $9K | Buy |
2,912
+2,006
| +221% | +$7.41K | ﹤0.01% | 3230 |
|
|
2015
Q4 | $4K | Hold |
906
| – | – | ﹤0.01% | 3241 |
|
|
2015
Q3 | $5K | Hold |
906
| – | – | ﹤0.01% | 3065 |
|
|
2015
Q2 | $7K | Sell |
906
-162
| -15% | -$1.39K | ﹤0.01% | 3045 |
|
|
2015
Q1 | $11K | Hold |
1,068
| – | – | ﹤0.01% | 2717 |
|
|
2014
Q4 | $13K | Hold |
1,068
| – | – | ﹤0.01% | 2634 |
|
|
2014
Q3 | $18K | Hold |
1,068
| – | – | ﹤0.01% | 2417 |
|
|
2014
Q2 | $13K | Buy |
1,068
+128
| +14% | +$1.21K | ﹤0.01% | 2644 |
|
|
2014
Q1 | $8K | Hold |
940
| – | – | ﹤0.01% | 2910 |
|
|
2013
Q4 | $6K | Buy |
940
+285
| +44% | +$1.47K | ﹤0.01% | 3034 |
|
|
2013
Q3 | $4K | Buy |
+655
| New | +$3.15K | ﹤0.01% | 3061 |
|
Other funds holding BDSI
BlackRock's BDSI Position: Q1 2022 in Review
BlackRock sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 7,305,512 shares — an estimated $22.6M sold.
BlackRock first reported a position in BDSI in Q3 2013 and held it in 31 quarters. The position peaked at $46.2M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- BlackRock reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- BlackRock sold 7,305,512 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $22.6M.
- BlackRock first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 31 quarters.
- BlackRock's BioDelivery Sciences International, Inc. position peaked at $46.2M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.